beta 2 Adrenergic Receptor Antikörper (AA 201-300)
-
- Target Alle beta 2 Adrenergic Receptor (ADRB2) Antikörper anzeigen
- beta 2 Adrenergic Receptor (ADRB2) (Adrenergic, beta-2-, Receptor, Surface (ADRB2))
-
Bindungsspezifität
- AA 201-300
-
Reaktivität
- Human, Ratte, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser beta 2 Adrenergic Receptor Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Kreuzreaktivität
- Human, Maus, Ratte
- Homologie
- Dog,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human of human ADRB2
- Isotyp
- IgG
-
-
- Applikationshinweise
-
WB 1:300-5000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
-
Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model." in: Journal of experimental & clinical cancer research : CR, Vol. 33, pp. 21, (2014) (PubMed).
: "Role of ?2-adrenoceptor-?-arrestin2-nuclear factor-?B signal transduction pathway and intervention effects of oxymatrine in ulcerative colitis." in: Chinese journal of integrative medicine, Vol. 18, Issue 7, pp. 514-21, (2012) (PubMed).
: "
-
Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model." in: Journal of experimental & clinical cancer research : CR, Vol. 33, pp. 21, (2014) (PubMed).
-
- Target
- beta 2 Adrenergic Receptor (ADRB2) (Adrenergic, beta-2-, Receptor, Surface (ADRB2))
- Andere Bezeichnung
- ADRB2 (ADRB2 Produkte)
- Synonyme
- zgc:162188 antikoerper, adrb2 antikoerper, Adrb-2 antikoerper, Badm antikoerper, Gpcr7 antikoerper, ADRB2R antikoerper, ADRBR antikoerper, B2AR antikoerper, BAR antikoerper, BETA2AR antikoerper, adrenoceptor beta 2 antikoerper, adrenoceptor beta 2, surface b antikoerper, beta2-adrenergic receptor antikoerper, adrenergic receptor, beta 2 antikoerper, ADRB2 antikoerper, adrb2b antikoerper, LOC100136153 antikoerper, Adrb2 antikoerper
- Hintergrund
-
Synonyms: BAR, B2AR, ADRBR, ADRB2R, BETA2AR, Beta-2 adrenergic receptor, Beta-2 adrenoreceptor, Beta-2 adrenoceptor, ADRB2
Background: Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. The beta-2-adrenergic receptor binds epinephrine with an approximately 3-fold greater affinity than it does norepinephrine.
- Gen-ID
- 154
- UniProt
- P07550
- Pathways
- cAMP Metabolic Process, Synaptic Membrane, Regulation of G-Protein Coupled Receptor Protein Signaling, Brown Fat Cell Differentiation
-